3 ms·
The cost of manufacturing the drug is only relevant if the drug can be discovered and proved effective by the Magic Drug Fairy. Here in the real world, that ma
by pfdietz 3y ago
The cost of manufacturing the drug is only relevant if the drug can be discovered and proved effective by the Magic Drug Fairy.
Here in the real world, that manufacturing cost is largely irrelevant.
- narrator 3y agoThis reminds me of P=NP. It's hard to find a sha256 with a given number of leading zeros, but it's super easy to verify. It's hard to make Microsoft Office, or a Pharmaceutical Drug, but easy to see that they work. The confusion is at the root of most economic fallacies.
- willcipriano 3y ago> the Magic Drug Fairy. Thats the government funded universities.
- pfdietz 3y agoThey do not, in fact, do the hard work of drug development.
- philipkglass 3y agoThe universities find compounds that work in cell cultures or mice. They don't currently optimize candidate compounds for use in humans or perform actual human clinical trials. In theory, there's no reason that a government couldn't fund all phases of drug development through final approval and then manufacture new drugs without seeking a profit. But most compounds that work in mice fail in clinical trials, and human testing is a lot more expensive than mouse testing. There would need to be consistent support for such a drug development program even though most attempts will fail and "breakthrough" drugs will arrive irregularly, separated by many years. It is politically difficult to maintain that sort of long term support in a system where voters and representatives are swayed by short-term arguments to cut programs that don't show results.
- vineyardmike 3y agoYou say all this, while the literal title of the article you're commenting on is "The cost of developing new drugs may be far lower than industry claims". I think this comment perfectly proves that this is relevant. Manufacturing is quite relevant. If the actual cost of "discovered and proved effective" is far lower than claimed, then manufacturability becomes a concern. If the cost of discovery and proven effectiveness is borne by governments and universities, then the manufacturing is the only cost borne by the pharmaceutical companies.
- pfdietz 3y agoThe article appears to imply that the direct cost of developing a successful drug is the relevant metric. It isn't; the cost must include the indirect costs of development on drugs that didn't pan out. And the vast majority of drug candidates don't pan out, often in Phase 3 trials where much of the cost has already been sunk. Put it another way: if making new drugs was so cheap and easy, drug companies would be doing that in competition with each other, and prices would be low as a result of that competition.
- vineyardmike 3y ago> if making new drugs was so cheap and easy, drug companies would be doing that in competition with each other They are. There is intense competition and lots of venture capital and research grants to fund research. > prices would be low as a result of that competition. Why? Patents end competition as soon as the research is successful. They have to compete to research the drug - and we see a vibrant competitive market for research - but they don't have to compete to sell the drug. We see this even when there are multiple brands competing to sell generic versions of drugs they didn't discover or spend R&D on. There is simply no market forces to lower medically necessary drug prices. The market is captive (people will die without certain medication), and thanks to patents, there is often no competition for years to allow people to price shop. I can buy ibuprofen or acetaminophen or aspirin for cheap at any drug store, because there is a competitive market for OTC pain meds. There is no OTC market for insulin, and people will die without it. Unsurprisingly, insulin is much more expensive, despite being discovered by a university and being over 100 years old. PreP (prevents HIV) research was entirely funded by US taxes, and the pills costs $2000/mo - despite being available from multiple companies including available as a generic. Why are companies that didn't pay to research the drug (and didn't take US Gov money to research it) charging $2000/mo? The only cost they incurred was manufacturing.
- maxerickson 3y agoI bet the manufacturing cost is the largely relevant factor once the patents expire. Which from the perspective of generic manufacturers, the drugs are discovered and proved effective by the Magic Drug Fairy.
- eitally 3y agoNot particularly, but there really isn't much difference between a generic drug plant and a branded factory. Same machines, same kinds of people, basically all the same.
- maxerickson 3y agoYes, that is why once regulatory exclusivity is removed, the market price tends to be based more or less on the manufacturing cost.